Developer docs
API playgroundTry for free, no card

Search company profiles

Faper Group

Full company profile

uuid000yimv

Namestring
Faper Group
Legal namestring
FAPER GROUP S.p.A.
Websiteurl
fapergroup.it
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Faper Group S.p.A. is a privately held Italian holding company founded in 2001 by inventor Fabio Perini and headquartered in Viareggio, Italy. The group operates across two principal industrial verticals: high-performance tissue paper converting machinery through its core subsidiary Futura S.p.A., and sterilization and infection control systems for hospitals and life science industries through Cisa Group. Its product portfolio includes Futura's automated converting lines (Andromeda series, Create technology for nonwovens), Plusline's packaging solutions (Pluspack FBO units), and Cisa's healthcare sterilization equipment, supported by a network of wholly-owned entities in Italy, North America, and Latin America serving over 85 countries.

The underlying technology is rooted in decades of mechanical and process engineering IP. Fabio Perini invented the first automatic tissue paper cutting machine in 1960 and holds nearly 100 patents, with the group collectively holding 200+ patents and prototypes. Futura Lab functions as a dedicated R&D and engineering training center. The current generation of converting lines features automatic hot roll changeover in 20 minutes, offline web lamination at speeds up to 1,000 m/min, and ergonomic automation that reduces operational cost per ton. Futura reports approximately 50 million euros in annual turnover, 172 employees, and 116 production lines installed worldwide.

Faper Group generates revenue primarily through direct enterprise sales of capital equipment to tissue paper manufacturers and healthcare facilities, complemented by installation, service, and aftermarket support. Customer segments include global tissue manufacturers (Sofidel, Lucart, Essity, Wepa, Irving Consumer Products) and Italian healthcare facilities served by Cisa. The group operates through wholly-owned direct sales subsidiaries in Italy, the United States, and Latin America, supplemented by trade-show-driven lead generation (INDEX23, MIAC, AIIC). Pricing is quote-based and negotiated directly with enterprise customers. The group has actively rationalized its portfolio since 2008, divesting Toscotec, Milltech, Focus, Perini Navi, and Celtech Business Park while adding Plusline and Cisa Brasil.

Short descriptiontext

Faper Group is a privately held Italian holding company founded in 2001 that operates Futura S.p.A. (tissue paper converting machinery) and Cisa Group (hospital sterilization and infection control systems), serving global tissue manufacturers and healthcare facilities through direct enterprise sales across Italy, North America, and Latin America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersViareggio, Italy
HQ citystring
Viareggio
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tissue converting machinery, nonwoven processing equipment, infection control systems, industrial packaging equipment, healthcare sterilization systems
NAICS code2 codes
  • Commercial and Service Industry Machinery Manufacturing333310
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • General Industrial Machinery & Equipment3560
  • Surgical & Medical Instruments & Apparatus3841
Product category
Industrial Tissue Converting Machinery
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Tissue Converting Machinery Sales
TypeHardware Sales
Description

Sale of high-performance converting lines and machines for tissue paper manufacturing. Includes Andromeda lines, Pluspack FBO units, and other converting equipment. Revenue generated from equipment sales, installation, and related services to tissue manufacturers worldwide.

fapergroup.it
2Sterilization and Infection Control Systems
TypeHardware Sales
Description

Sale and service of sterilization and infection control systems for hospitals and life science industries through Cisa Group division.

fapergroup.it
3Advisory Services
TypeProfessional Services
Description

Advisory services for development and real estate investments, supporting entrepreneurial initiatives.

fapergroup.it
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Faper Group S.p.A. is an Italian industrial holding company that designs, manufactures, and sells high-performance tissue paper converting machinery and packaging equipment through its subsidiary Futura S.p.A. (including the Andromeda and Create converting lines and Pluspack FBO units), and provides sterilization and infection control systems for hospitals and life science industries through its subsidiary Cisa Group. The group sells equipment and integrated solutions directly to industrial tissue manufacturers and to healthcare facilities, supported by an installed base of 116 production lines across more than 85 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 116 production lines installed worldwide
+4 more records
Product overview1 text field

Faper Group is a holding company founded in 2001 by Fabio Perini, focused on two core activities: high-performance solutions for tissue paper converting and sterilization/infection control systems for hospitals. The group's product portfolio includes Futura S.p.A. (tissue converting machinery including Andromeda and Create lines), Cisa Group (medical infection control systems), Plusline (packaging solutions acquired by Futura), and Perini Business Park (real estate advisory in Brazil). Futura serves as the core converting technology business with 172 employees, 116 production lines installed worldwide, and approximately 50 million euros in annual turnover. The group operates across Italy, the United States, and Latin America, providing local service and support in over 85 countries.

Product and service4 records
1Andromeda Tissue Converting Line
CategoryTissue converting machinery
Description

High-automation tissue converting production line developed by Futura S.p.A., with Andromeda 3 being the latest generation redefining quality, efficiency, ergonomics, and safety in tissue converting.

2Create Nonwoven Converting Solution
CategoryNonwoven processing machinery
Description

Innovative converting solution for the nonwoven sector developed by Futura S.p.A., enabling process automation, product quality, safety, and operational flexibility for hygiene and medical nonwoven manufacturers.

3Pluspack FBO Packaging Unit
CategoryIndustrial packaging equipment
Description

State-of-the-art Fold Box Over packaging unit developed by Plusline for tissue packaging, designed for extraordinary adaptability to specific customer needs; purchased by customers including Irving Consumer Products.

4Cisa Group Sterilization and Infection Control Systems
CategoryHealthcare sterilization and infection control equipment
Description

Sterilization and infection control systems sold by Cisa Group to hospitals, healthcare facilities, and life science industries, focused on reducing waste, cutting costs, and supporting environmental sustainability.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Faper Group held a 49% partnership stake in Visualize IT S.r.l., a startup focused on innovation. The partnership provided financial support and organizational guidance. The startup successfully completed validation and early scaling-up phases, after which Faper Group divested its minority shareholding to next phase partners.

Recent move13 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Austrian pulp, paper, and tissue machinery giant (multi-billion revenue). Operates broadly across the same tissue-converting space as Faper but as part of a much larger industrial portfolio; competes in large-scale tissue lines that often include Futura-grade converting equipment.

TypeBroad incumbent
Description

Swedish-listed provider of hospital sterilization, disinfection, and infection control solutions for life sciences and healthcare. Direct competitor to Cisa's infection-control offering, with broader geographic reach and product breadth.

TypeDirect peer
Description

Italian-headquartered manufacturer of tissue and paper converting machinery that was formerly part of Faper (divested 2008). Direct competitor serving the same tier-1 tissue converters (Sofidel, Essity, Lucart) with overlapping product lines, including towel and tissue converting systems.

4BW Papersystems
TypeDirect peer
Description

Specialty machinery builder for tissue, paper, and packaging converting headquartered in the US/EU. Comparable to Futura's converting and Plusline's packaging product families, serving many of the same global converters.

5STERIS
TypeBroad incumbent
Description

Multi-billion-dollar US-listed leader in hospital sterilization and infection prevention. Comparable to Cisa Group as a sterilization/infection-control incumbent, but at vastly greater scale and global hospital installed base.

TypeDirect peer
Description

US-based manufacturer of converting machinery for tissue, nonwovens, and packaging, including rewinders and embossing units. Comparable peer because it competes head-to-head with Futura/Plusline in tissue converting and packaging lines.

TypeBroad incumbent
Description

Global healthcare conglomerate with major infection-prevention and sterilization-adjacent product portfolios. Overlaps with Cisa's hospital-focused infection-control mission at vastly greater scale, defining competitive benchmark rather than head-to-head rivalry.

TypeBroad incumbent
Description

Finnish global leader in pulp, paper, and tissue machinery and automation. Much larger incumbent with overlapping tissue-converting scope; reference benchmark for the segment in which Futura competes.

TypeDirect peer
Description

Italian tissue and nonwovens converting machinery specialist headquartered near Lucca, supplying complete turnkey lines (winders, rewinders, packaging) to global tissue makers. Directly comparable to Futura's Andromeda/Pluspack stack in product, geography, and customer base.

10Körber Tissue (Körber Business Area Tissue)
TypeDirect peer
Description

German engineering group's tissue division supplies complete converting lines, packaging, and digital solutions to global tissue producers (Sofidel, Kimberly-Clark, etc.). Overlaps directly with Faper's combined Futura (converting) plus Plusline (packaging) offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries10 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Faper Group

Industrial Tissue Converting Machineryfapergroup.it

Faper Group is a privately held Italian holding company founded in 2001 that operates Futura S.p.A. (tissue paper converting machinery) and Cisa Group (hospital sterilization and infection control systems), serving global tissue manufacturers and healthcare facilities through direct enterprise sales across Italy, North America, and Latin America.

What Faper Group does

Faper Group S.p.A. is a privately held Italian holding company founded in 2001 by inventor Fabio Perini and headquartered in Viareggio, Italy. The group operates across two principal industrial verticals: high-performance tissue paper converting machinery through its core subsidiary Futura S.p.A., and sterilization and infection control systems for hospitals and life science industries through Cisa Group. Its product portfolio includes Futura's automated converting lines (Andromeda series, Create technology for nonwovens), Plusline's packaging solutions (Pluspack FBO units), and Cisa's healthcare sterilization equipment, supported by a network of wholly-owned entities in Italy, North America, and Latin America serving over 85 countries.

The underlying technology is rooted in decades of mechanical and process engineering IP. Fabio Perini invented the first automatic tissue paper cutting machine in 1960 and holds nearly 100 patents, with the group collectively holding 200+ patents and prototypes. Futura Lab functions as a dedicated R&D and engineering training center. The current generation of converting lines features automatic hot roll changeover in 20 minutes, offline web lamination at speeds up to 1,000 m/min, and ergonomic automation that reduces operational cost per ton. Futura reports approximately 50 million euros in annual turnover, 172 employees, and 116 production lines installed worldwide.

Faper Group generates revenue primarily through direct enterprise sales of capital equipment to tissue paper manufacturers and healthcare facilities, complemented by installation, service, and aftermarket support. Customer segments include global tissue manufacturers (Sofidel, Lucart, Essity, Wepa, Irving Consumer Products) and Italian healthcare facilities served by Cisa. The group operates through wholly-owned direct sales subsidiaries in Italy, the United States, and Latin America, supplemented by trade-show-driven lead generation (INDEX23, MIAC, AIIC). Pricing is quote-based and negotiated directly with enterprise customers. The group has actively rationalized its portfolio since 2008, divesting Toscotec, Milltech, Focus, Perini Navi, and Celtech Business Park while adding Plusline and Cisa Brasil.

Faper Group firmographics

Firmographics
Name
Faper Group
Legal name
FAPER GROUP S.p.A.
Website
https://fapergroup.it
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
1–10 employees
Short description
Faper Group is a privately held Italian holding company founded in 2001 that operates Futura S.p.A. (tissue paper converting machinery) and Cisa Group (hospital sterilization and infection control systems), serving global tissue manufacturers and healthcare facilities through direct enterprise sales across Italy, North America, and Latin America.
Ownership category
akta.pro rank

Where Faper Group is headquartered

Location

Headquarters

HQ city
Viareggio
HQ country
Italy
HQ region
Europe

Offices10 records

Markets served

Faper Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Tissue Converting Machinery Sales: Sale of high-performance converting lines and machines for tissue paper manufacturing. Includes Andromeda lines, Pluspack FBO units, and other converting equipment. Revenue generated from equipment sales, installation, and related services to tissue manufacturers worldwide.
  2. Sterilization and Infection Control Systems: Sale and service of sterilization and infection control systems for hospitals and life science industries through Cisa Group division.
  3. Advisory Services: Advisory services for development and real estate investments, supporting entrepreneurial initiatives.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels3 records

Faper Group product offering

Product offering

Core offering

Faper Group S.p.A. is an Italian industrial holding company that designs, manufactures, and sells high-performance tissue paper converting machinery and packaging equipment through its subsidiary Futura S.p.A. (including the Andromeda and Create converting lines and Pluspack FBO units), and provides sterilization and infection control systems for hospitals and life science industries through its subsidiary Cisa Group. The group sells equipment and integrated solutions directly to industrial tissue manufacturers and to healthcare facilities, supported by an installed base of 116 production lines across more than 85 countries.

Product overview

Faper Group is a holding company founded in 2001 by Fabio Perini, focused on two core activities: high-performance solutions for tissue paper converting and sterilization/infection control systems for hospitals. The group's product portfolio includes Futura S.p.A. (tissue converting machinery including Andromeda and Create lines), Cisa Group (medical infection control systems), Plusline (packaging solutions acquired by Futura), and Perini Business Park (real estate advisory in Brazil). Futura serves as the core converting technology business with 172 employees, 116 production lines installed worldwide, and approximately 50 million euros in annual turnover. The group operates across Italy, the United States, and Latin America, providing local service and support in over 85 countries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Andromeda Tissue Converting Line High-automation tissue converting production line developed by Futura S.p.A., with Andromeda 3 being the latest generation redefining quality, efficiency, ergonomics, and safety in tissue converting.
  • Create Nonwoven Converting Solution Innovative converting solution for the nonwoven sector developed by Futura S.p.A., enabling process automation, product quality, safety, and operational flexibility for hygiene and medical nonwoven manufacturers.
  • Pluspack FBO Packaging Unit State-of-the-art Fold Box Over packaging unit developed by Plusline for tissue packaging, designed for extraordinary adaptability to specific customer needs; purchased by customers including Irving Consumer Products.
  • Cisa Group Sterilization and Infection Control Systems Sterilization and infection control systems sold by Cisa Group to hospitals, healthcare facilities, and life science industries, focused on reducing waste, cutting costs, and supporting environmental sustainability.

Quantifiable outcome

  • 116 production lines installed worldwide
  • +4 more outcomes

Companies that use Faper Group

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Faper Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Faper Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Visualize IT S.r.l.minorStrategic or Co-development Partner · 1 January 2021Faper Group held a 49% partnership stake in Visualize IT S.r.l., a startup focused on innovation. The partnership provided financial support and organizational guidance. The startup successfully completed validation and early scaling-up phases, after which Faper Group divested its minority shareholding to next phase partners.

Scale indicators7 records

Recent moves13 records

Expansion highlights6 records

Faper Group competitors and assessment

Company assessment

Broad incumbents

  • Andritz: Austrian pulp, paper, and tissue machinery giant (multi-billion revenue). Operates broadly across the same tissue-converting space as Faper but as part of a much larger industrial portfolio; competes in large-scale tissue lines that often include Futura-grade converting equipment.
  • Getinge: Swedish-listed provider of hospital sterilization, disinfection, and infection control solutions for life sciences and healthcare. Direct competitor to Cisa's infection-control offering, with broader geographic reach and product breadth.
  • STERIS: Multi-billion-dollar US-listed leader in hospital sterilization and infection prevention. Comparable to Cisa Group as a sterilization/infection-control incumbent, but at vastly greater scale and global hospital installed base.
  • 3M Health Care: Global healthcare conglomerate with major infection-prevention and sterilization-adjacent product portfolios. Overlaps with Cisa's hospital-focused infection-control mission at vastly greater scale, defining competitive benchmark rather than head-to-head rivalry.
  • Valmet: Finnish global leader in pulp, paper, and tissue machinery and automation. Much larger incumbent with overlapping tissue-converting scope; reference benchmark for the segment in which Futura competes.

Direct peers

  • Toscotec: Italian-headquartered manufacturer of tissue and paper converting machinery that was formerly part of Faper (divested 2008). Direct competitor serving the same tier-1 tissue converters (Sofidel, Essity, Lucart) with overlapping product lines, including towel and tissue converting systems.
  • BW Papersystems: Specialty machinery builder for tissue, paper, and packaging converting headquartered in the US/EU. Comparable to Futura's converting and Plusline's packaging product families, serving many of the same global converters.
  • PCMC (Paper Converting Machine Company): US-based manufacturer of converting machinery for tissue, nonwovens, and packaging, including rewinders and embossing units. Comparable peer because it competes head-to-head with Futura/Plusline in tissue converting and packaging lines.
  • A.Celli Group: Italian tissue and nonwovens converting machinery specialist headquartered near Lucca, supplying complete turnkey lines (winders, rewinders, packaging) to global tissue makers. Directly comparable to Futura's Andromeda/Pluspack stack in product, geography, and customer base.
  • Körber Tissue (Körber Business Area Tissue): German engineering group's tissue division supplies complete converting lines, packaging, and digital solutions to global tissue producers (Sofidel, Kimberly-Clark, etc.). Overlaps directly with Faper's combined Futura (converting) plus Plusline (packaging) offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Faper Group social profiles

Digital presence

Faper Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Faper Group leadership team

Management profile

Number of profiles

Profiles8 records

Faper Group subsidiaries and ownership

Company hierarchy

Subsidiaries10 records

Faper Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Faper Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Faper Group

What does Faper Group do?

Faper Group S.p.A. is an Italian industrial holding company that designs, manufactures, and sells high-performance tissue paper converting machinery and packaging equipment through its subsidiary Futura S.p.A. (including the Andromeda and Create converting lines and Pluspack FBO units), and provides sterilization and infection control systems for hospitals and life science industries through its subsidiary Cisa Group. The group sells equipment and integrated solutions directly to industrial tissue manufacturers and to healthcare facilities, supported by an installed base of 116 production lines across more than 85 countries.

Is Faper Group a public or private company?

Faper Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Faper Group founded?

Faper Group was founded in 2001. It employs 1 to 10 people.

Where is Faper Group based?

Faper Group is headquartered in Viareggio, Italy, in the Europe region.

How does Faper Group make money?

Three revenue lines are on record. Tissue Converting Machinery Sales are the primary driver. The others are sterilization and Infection Control Systems and advisory Services.

Who are Faper Group's main competitors?

Broad incumbents on record are Andritz, Getinge, STERIS, 3M Health Care and Valmet. Direct peers are Toscotec, BW Papersystems, PCMC (Paper Converting Machine Company), A.Celli Group and Körber Tissue (Körber Business Area Tissue).

Does Faper Group have an API?

No public API is recorded for Faper Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales